Year in Review 2024 - Transformative FDA Approvals in Precision Onco…

Oncology 2024 Year in Review

V. Subbiah

ESMO 2024 Summary: Management of Oligoprogressive Disease - Patients…

2024 ESMO Annual Meeting Insights Hub

R. Van den Begin

IO Advances in Metastatic NSCLC Treatment

Fox Chase Cancer Center

H. Borghaei

Metastatic EGFRm NSCLC: 1L Therapy Options

University of Colorado Cancer Center

T. Patil

2024 Year in Review: Neuro-oncology Focus: Glioblastoma Trials

Soma Sengupta

2025 Update on IDH-Mutant Gliomas

Jan Drappatz

Rad Onc 101: Radiation Oncology Basics

Nina Niu Sanford

N. Sanford

Systemic Therapy for HER2+ mBC With CNS Involvement

Total Health

E. Cobain

Delayed Diagnosis and Diagnostic Imprinting in Pediatric CNS Tumors:…

Ibrahim Qaddoumi

ASCO® 2024 Lung Cancer Highlights: Top Abstracts Including BEAT-SC, …

2024 ASCO® Annual Meeting Insights Hub

B. Halmos

73 y/o Never-Smoker With Stage IV EGFRm NSCLC Presented With Progres…

PrecisCa

J. West, M. Ginsberg, S. Ramalingam, S. Force, C. Robinson

cfDNA for Liquid Biopsy for Patients With Glioblastoma

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

S. Bagley

2025 Updates in HER2+ mBC: 1L, 2L, and Beyond (With a Focus on Brain…

Stanford Medicine

M. Dolezal

IDH-Mutant Diffuse Glioma: Best Practices for Multidisciplinary Appr…

Ruham Nasany

2024 Neuro-Oncology Update: Brain Tumors

Scripps Health

T. McGranahan

Treatment Strategies for Metastatic HER2-Mutant NSCLC

UNC Lineberger Comprehensive Cancer Center

S. Patel

Overview of CNS Cancers

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

V. Venur

Overview and Updates in Brain Tumors

Henry Friedman

2025 Updates in HER2+ mBC: Frontline Therapy, CNS Metastasis Managem…

UChicago Medicine

S. Yarlagadda

EGFR-Mutated Lung Cancer: CNS Metastases Co-Mutations & Treatment

GRACE

I. Dagogo-Jack, J. Rotow, M. Shields, A. Cooper, A. Qin